Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence

被引：0
|
作者：
Anna Citarella
Marie Linder
Helle Kieler
Ingegärd Anveden Berglind
Anders Sundström
Björn Wettermark
Morten Andersen
机构：
[1] Karolinska Institutet,Centre for Pharmacoepidemiology (CPE), Department of Medicine
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Persistence; Statin; Therapy discontinuation; Pharmacoepidemiology; Lipid values;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 357
页数：8
相关论文
共 50 条
  • [1] Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence
    Citarella, Anna
    Linder, Marie
    Kieler, Helle
    Berglind, Ingegard Anveden
    Sundstrom, Anders
    Wettermark, Bjorn
    Andersen, Morten
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (03) : 349 - 357
  • [2] Effect Of Statin Therapy In Stroke Patients With Low Baseline Low-density Lipoprotein Cholesterol
    Kim, Yong Soo
    Jeong, Han-gil
    Park, Chan-Young
    Kim, Museong
    Lee, Subin
    [J]. STROKE, 2023, 54
  • [3] Effect of Statin Therapy on Cardiovascular Outcome in Stroke Patients with Low Baseline Low-Density Lipoprotein Cholesterol
    Kim, Yong Soo
    Jeong, Han-Gil
    Chang, Jun Young
    Kim, Jun Yup
    Kim, Beom Joon
    Bae, Hee-Joon
    Han, Moon-Ku
    [J]. ANNALS OF NEUROLOGY, 2024, 95 (05) : 876 - 885
  • [4] Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT
    Oyama, Kazuma
    Giugliano, Robert P.
    Blazing, Michael A.
    Park, Jeong-Gun
    Tershakovec, Andrew M.
    Sabatine, Marc S.
    Cannon, Christopher P.
    Braunwald, Eugene
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (15) : 1499 - 1507
  • [5] Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment
    Lahoz, C
    Peña, R
    Mostaza, JM
    Laguna, F
    García-Iglesias, MF
    Taboada, M
    Pintó, X
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (06): : 741 - 747
  • [6] Statin Therapy in Patients With Low Serum Levels of Low-Density Lipoprotein Cholesterol
    Tsujimoto, Tetsuro
    Kajio, Hiroshi
    Sugiyama, Takehiro
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (11): : 1947 - 1954
  • [7] The future of low-density lipoprotein cholesterol lowering therapy: An end to statin exceptionalism?
    Khera, Amit V.
    Natarajan, Pradeep
    Kathiresan, Sekar
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (10) : 1062 - 1064
  • [8] Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
    Zhao, Yuqi
    Zhou, Ying
    Zhou, Huan
    Gong, Xiaoxian
    Luo, Zhongyu
    Li, Jiaping
    Sun, Jianzhong
    Lou, Min
    Yan, Shenqiang
    [J]. NEUROIMAGE-CLINICAL, 2023, 39
  • [9] Impact of statin therapy on EVT for PAD with decreased low-density lipoprotein cholesterol
    Noto, T.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2910 - 2910
  • [10] LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS, STATIN THERAPY, AND THE INCIDENCE OF PLAQUE RUPTURE
    Kurihara, Osamu
    Kim, Hyung Oh
    Russo, Michele
    Araki, Makoto
    Nakajima, Akihiro
    Lee, Hang
    Takano, Masamichi
    Mizuno, Kyoichi
    Jang, Ik-Kyung
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 84 - 84
12345